(Q43157760)

English

Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor

scientific article published in June 2010

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

M Kernt

1

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

R G Liegl

2

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

J Rueping

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

A S Neubauer

4

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

C Haritoglou

5

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

C A Lackerbauer

6

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

K H Eibl

7

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

M W Ulbig

8

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

A Kampik

9

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

publication date

1 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Growth Factors Journal

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

28

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

211-220

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF/MEK/ERK pathway in tumor cells and tyrosine kinases VEGFR/PDGFR in tumor vasculature

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Role of platelet-derived growth factors in physiology and medicine

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Diabetic retinopathy: seeing beyond glucose-induced microvascular disease.

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

BAY 43-9006 inhibition of oncogenic RET mutants

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Anti-vascular endothelial growth factor therapy for neovascular ocular diseases other than age-related macular degeneration

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Causes and prevalence of visual impairment among adults in the United States

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Retinal and choroidal angiogenesis: pathophysiology and strategies for inhibition

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Ranibizumab combined with low-dose sorafenib for exudative age-related macular degeneration

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

The astroglial-derived S100beta protein stimulates the expression of nitric oxide synthase in rodent macrophages through p38 MAP kinase activation

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Retinal glial cells stimulate microvascular pericyte proliferation via fibroblast growth factor and platelet-derived growth factor in vitro

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Inhibition of platelet-derived growth factor B signaling enhances the efficacy of anti-vascular endothelial growth factor therapy in multiple models of ocular neovascularization

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Cytoprotective effects of a blue light-filtering intraocular lens on human retinal pigment epithelium by reducing phototoxic effects on vascular endothelial growth factor-alpha, Bax, and Bcl-2 expression

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

In vitro safety of intravitreal moxifloxacin for endophthalmitis treatment

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Resolution of macular oedema in occult choroidal neovascularization under oral Sorafenib treatment

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Astrocytes induce neural microvascular endothelial cells to form capillary-like structures in vitro

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Sorafenib blocks the RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5.

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Blood-retinal barrier and autofluorescence of the posterior polar retina in long-standing pseudophakia

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Combination angiostatic therapies: current status.

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Ranibizumab for neovascular age-related macular degeneration

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Role of growth factors and the wound healing response in age-related macular degeneration

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Photoreceptor-specific expression of platelet-derived growth factor-B results in traction retinal detachment

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

BAY 43-9006 exhibits broad spectrum oral antitumor activity and targets the RAF/MEK/ERK pathway and receptor tyrosine kinases involved in tumor progression and angiogenesis

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Vascular endothelial growth factors and angiogenesis in eye disease

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Mechanisms for the induction of HNE- MDA- and AGE-adducts, RAGE and VEGF in retinal pigment epithelial cells

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

The S100 protein family: history, function, and expression

1 reference

https://api.crossref.org/works/10.3109%2F08977191003604505

21 January 2018

Identifiers

10.3109/08977191003604505

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43157760&oldid=1982348183"